By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catalyst Pharmaceuticals (CPRX) Initiates Rolling NDA Submission For Firdapse For The Treatment Of Lambert-Eaton Myasthenic Syndrome (LEMS) 7/22/2015 2:03:56 PM
Catalyst Pharmaceuticals (CPRX) Appoints Dr. Gary Ingenito As Chief Medical Officer 6/30/2015 7:27:18 AM
Catalyst Pharmaceuticals (CPRX) Joins Russell 2000, 3000 And Global Indexes 6/29/2015 11:50:02 AM
Catalyst Pharmaceuticals (CPRX) Announces Encouraging Top-Line Results In Proof-Of-Concept Trial Of Vigabatrin In Patients With Treatment-Refractory Tourette's Disorder 6/24/2015 9:47:27 AM
Catalyst Pharmaceuticals (CPRX) Names Richard J. Daly Interim Chief Commercial Officer 5/28/2015 11:04:32 AM
Catalyst Pharmaceuticals (CPRX) To Present At The Jefferies and Co. 2015 Healthcare Conference 5/27/2015 7:24:21 AM
Catalyst Pharmaceuticals (CPRX) Announces First Quarter 2015 Financial Results And Provides Corporate Update 5/11/2015 4:46:30 PM
Catalyst Pharmaceuticals (CPRX) To Hold First Quarter Financial Results And Corporate Update Conference Call And Webcast On Tuesday, May 12th, 2015 5/4/2015 2:35:16 PM
Catalyst Pharmaceuticals (CPRX) Announces Oral Presentation Of Firdapse Phase 3 Trial Data At American Academy of Neurology Annual Meeting 4/15/2015 3:09:16 PM
Catalyst Pharmaceuticals (CPRX) Announces Oral Presentation Of Firdapse Phase 3 Trial Data At American Academy of Neurology Annual Meeting (AAN) 4/14/2015 10:51:43 AM
12345678910...
//-->